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ABSTRACT
Colorectal cancer (CRC), with multifactorial influences of genetic, molecular,
inflammatory, and environmental factors, is a leading cause of cancer-related deaths. Due to the
high diversity and concentration of microbes found in the human colon, the microbiome has
become a prime suspect of being a biological contributor. This prompts the need to investigate
the relationship between microorganisms and CRC. Recent studies have shown that
Fusobacterium nucleatum, Campylobacter showae, Leptrotrichia buccalis, and Selenomonas
sputigena are overrepresented in colon tumors. These anaerobes have known associations to the
oral microbiome and cause infections. Here, these findings are further expanded in an
experimental attempt to investigate a possible etiological relationship between the four microbes
and CRC. This was done by examining bacterial biofilm impact on the viability of CRC. Crystal
violet biofilm assays showed that each of the four anaerobes are capable of producing biofilms,
which is a known contributor to disease and has been proven to alter host tissue
microenvironment of the human colon. The images of bacterial biofilms grown in presence and
absence of CRC cells were generated through confocal microscopy studies. Co-cultured bacterial
and cellular formation was visualized in 2D and 3D perspectives using ImageJ and Icy,
respectively. Comstat2 was used to quantitatively analyze 3D biofilm characteristics. The results
showed that L. buccalis is a prime suspect of possessing key “driver” genes that not only
encouraged the proliferation of CRC cells but also minimized cell deaths. Furthermore, the
relationship between bacterial biofilms and CRC is not only statistically significant but suggests
that one factor influences the other inasmuch as the opposite holds true.
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INTRODUCTION
The History of Cancer: Past to Present
Siddhartha Mukherjee’s The Emperor of all Maladies: A Biography of Cancer explains
that the first discovery of cancer was made by the Egyptian physician Imhotep in 2625 BC, in
which the Egyptian described the disease as “bulging masses on the breast” (Mukherjee, 2011,
p.39) that is “…large, spreading, and hard” (Mukherjee, 2011, p.39). Scientists today know this
disease as breast cancer. However, Mukherjee further explains that after this discovery, there was
no mention of such cases until 440 BC. The records, written by Greek historian Herodotus,
foretell a story of how the queen of Persia, Atossa, noticed “a bleeding lump in her breast”
(Mukherjee, 2011. p.39) that is today described as inflammatory breast cancer where malignant
cells invade the lymph glands of the breast, the infection made manifest as a red, swollen mass
(Mukherjee, 2011).
However, despite first discoveries being recorded in mid-2000 BC, there is evidence that
cancer existed before it was documented. In 1914, an excavation in southeastern Africa done by
a team of archaeologists uncovered a jaw bone that had lymphoma, which is a type of cancer that
initiates in cells whose origins comes from the body’s immune system (American Cancer
Society, 2016), and was dated from 4000 BC. These findings indicate that cancer has been
around for a very long time. Yet, despite its ancient existence, its occurrence was notably rare
throughout human history.
The author contributes this rarity to the fact that cancer is a disease dependent upon the
age of individuals (Mukherjee, 2011). He explains that in ancient times, people simply did not
live long enough for cancer to occur. For example, the statistics given by the Centers of Disease
Control explain that 0.44% of women who are now 30 will get breast cancer sometime during
the next 10 years (Centers for Disease Control and Prevention [CDC], 2015). For women who
are sixty years old today, the chances of getting breast cancer within the next ten years increases
to 3.46% (i.e., 3 or 4 out of every 100 women who are 60 years old will get breast cancer by the
age of 70) (CDC, 2015). Mukherjee explains that human beings of ancient past were done in by
other diseases long before cancer could emerge. The author goes on to explain that 19th-century
physicians thought that cancer was caused by civilization, by the “rush and whirl of modern life,
2

which somehow incited pathological growth in the body” (Mukherjee, 2011, p.41). While the
physicians were correct to link cancer to civilization, Mukherjee argues that cancer was not
caused by civilization; instead, though the extension of human life, “civilization unveiled it”
(Mukherjee, 2011, p.41).
Since then, cancer has expanded into many types – its nomenclature contingent on the in
situ origin of diseased tissues. These cases have elicited traditional paradigms used to study
cancer, such as surgery, biopsy, and autopsy techniques (Mukherjee, 2011). Mukherjee compares
the diagnosis of cancer in the past to today’s time, explaining that the death of a child with
leukemia – a type of cancer that impacts cells originating in the bone marrow such as white
blood cells (National Cancer Institute, 2016) – in the 1850s would have been diagnosed as an
abscess or infection. However, with the introduction of techniques such as the mammography to
detect breast cancer in its early stages and many others, the rate at which cancer has been
recognized sharply increased (Mukherjee, 2011). In 1900, tuberculosis was the most common
reason for mortality in America followed closely by pneumonia, diarrhea, and gastroenteritis.
Cancer was placed seventh. By the early 1940s, cancer skyrocketed to the top of the list – second
only to heart disease (Mukherjee, 2011). This was due not only to the development of treatments
for other diseases but also because of the increasing awareness of cancer.
The rise of cancer as a dominant force that took the lives of many prompted the urgent
need to understand its roots and causes. Early experiments accumulated the evidence that cancer
resulted from fixed changes which broke off the cellular chains that held them down, allowing
them to grow uncontrollably (Varmus, 1989). It was observed that daughter cancer cells
resembled a phenotypic morphology that characterized the cancerous state its predecessor
exhibited. Many of the experiments performed included the use of physical and chemical agents
that acted as mutagens to induce cancerous growth (Pierotti, Sozzi, and Croce, 2003; Varmus,
1989) and epidemiological studies that linked an individual’s lifestyle to cancer, suggesting that
cancer could also rise through environmental factors (Varmus, 1989; Weissman, 1979).
Together, they formed the basis that cancer is the result of alterations that occur in the DNA, or
more specifically, of the structural and/or functional alterations that occur in specific genes
whose job is to control the life cycle of cells (Yokota, 2000; Bernards and Weinberg, 2002).
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These genes are classified into two key categories that have revolutionized our understanding of
how cancer works at the molecular level: oncogenes and tumor suppressor genes (Fig. 1).

Figure 1. Impact of oncogenes and tumor suppressor genes on cell growth control. Protooncogenes perform normal cellular functions where a change in the gene sequence could lead to
gross proliferation of cells. In contrast, tumor suppressor genes regulate the cell cycle, where its
inactivation could disrupt cell behavior, allowing cells to proceed through the cell cycle virtually
unchecked. As shown above, in a normal cell, proto-oncogenes act as the gas, promoting cell
growth and division. Tumor suppressor genes are analogous to the brakes, preventing the cell
from growing through division at inappropriate times. Adapted from
http://www.rerf.jp/dept/radi/eng/oncog.html.
Although the term ‘oncogene’ was first coined by George Todaro and Robert Huebner in
1969 (Mukherjee, 2011), the work began in earnest with the virologist Francis Peyton Rous’s
discovery of the Rous sarcoma virus (RSV). RSV, found in excised fibrosarcomas (i.e.,
connective tissue tumors) (Lodish, Berk, and Zipursky et al., 2000), could induce solid tumors in
chickens infected by the virus (Bister, 2015). These findings were then built upon with the
discovery of RSV as a transforming principle by Peter Duesberg and Peter Vogt (1970) where
the RNA of transforming derivatives of sarcoma viruses were shown to have two RNA subunits,
denoted a and b, while the RNA of non-transforming derivatives were shown to have only the b
subunit. This suggested that the a subunit present in transforming derivatives was responsible for
inducing the oncogenic phenotype (Duesberg and Vogt, 1970). Their hypothesis was later
confirmed in a temperature-based experiment by Steve Martin (1970), revealing the existence of
4

the viral src gene, which was capable of inducing oncogenic properties. The src gene,
specifically named v-src, was defined to be the first oncogene discovered while its cellular
homolog was given the name c-src (Martin, 2001). Many cellular oncogenes are, in fact, protooncogenes, or genes that perform normal cellular functions such as the promotion of cell growth
and release of growth hormones, transcription factors, cell signaling molecules, etc. (Lodish,
Berk, and Zipursky et al., 2000). Multiple studies conducted since have revealed numerous
proto-oncogenes.
The discoveries of the 1970s continued over the next two decades, laying the groundwork
for not just the findings of oncogenes but also to the other vital class of genes that defines cancer
genetics: tumor suppressor genes. This discovery started with the observation that normal cells
fused with tumor cells, termed hybrid cells, grown in animals did not display any malignant
behavior (Ephrussi et al., 1969; Harris, 1988; Ho Park and Vogelstein, 2003). This observation
prompted the hypothesis that the genetics of nonmalignant cells somehow suppressed the
tumorigenicity of malignant cells. When propagating hybrid cells for longer periods of time in
culture, the malignant phenotype returned. Karyotypic studies revealed hybrid cells that reverted
back to malignant phenotype had lost certain chromosomes associated with normal cells and thus
supported the hypothesis that tumorigenicity could be suppressed even in the presence of active
oncogenic activities in hybrid cells (Ho Park and Vogelstein, 2003; Geiser et al., 1986).
While the somatic hybridization experiments did not directly discover tumor suppressor
genes, they convinced cancer researchers that there were genes whose sole duty was to regulate
pathological growth of malignant cells. Subsequent experiments began with two unique cases of
retinoblastoma (RB) (Knudson, 1971), a type of cancer that initiates in the far backend of the
retina (American Cancer Society, 2016). In both cases, the disease occurred in children;
however, in one case, the children’s parents also had the disease, while in another case, the
parents of the diseased also had RB (Knudson, 1971).
These cases of RB prompted Knudson (1971) to provide an explanation for the
development of the disease. He proposed that RB was the result of two mutational events in
which biallelic inactivation of the RB gene, called RB1, was needed for the eye cancer to occur
(Ho Park and Vogelstein, 2003). In expanding his hypothesis, Knudson (1971) explained that
children whose parents had retinoblastoma only had one functional copy of the RB1 gene
5

because they inherited a non-functional copy from the diseased parent (i.e., familial). Therefore,
only one mutational event was needed in order for the disease to occur. In the second, the
children were born with two functional copies where two mutational events were needed to
initiate the disease (i.e., sporadic) (Knudson, 1971). Karyotypic analysis and cytogenetic
experiments (Orye, Delbeke, Vandenabeele, 1974; Francke, 1976; Benedict et al., 1983)
revealed that Knudson’s proposal was consistent, prompting RB to be the first tumor suppressor
gene discovered.
The discovery of oncogenes and tumor suppressor genes fundamentally altered the way
cancer research is done today because they have cemented the idea that cancer is a genetic
disease. Tumor suppressor genes act as regulators by controlling cell division, repairing DNA
damage, or controlling apoptosis (i.e., programmed cell death) (American Cancer Society, 2016)
where its biallelic inactivation events (i.e., both alleles must be mutated in order for the disease to
occur) prompts the development of tumors. Oncogenes, its polar opposite, are the result of

activating proto-oncogenes (American Cancer Society, 2016). When comparing the initiation of
tumor suppressor genes to oncogenes, one sees that the latter is usually dominant while the
former is usually recessive. There are, of course, exceptions to this hypothesis; the most notable
one being the p53 tumor suppressor gene in which it was shown that the suppression of wild-type
p53 gene is not necessary for tumorigenesis (Baker et al., 1990).
These two concepts have also paved the way for a relatively recent field that has today
become a critical aspect of cancer biology: cancer epigenetics. Epigenetics, a term coined by
Conrad Waddington (1939), was originally defined as “the casual interactions between genes and
their products, which bring the phenotype into being” (Esteller, 2008, p.1148; Waddington,
1939). Following the works of Holliday (1987), the modern term has altered to mean changes in
gene expression that are not the result of alterations in the DNA sequence and thus can also be
passed down from parent to child.
In the field of cancer biology, epigenetics is generally studied to understand how external
factors are used to influence disease progression from non-malignant to malignant cells such as
how certain drugs can be used to activate tumor suppressor genes by targeting the DNA
methylation and histone modification of proteins produced by these genes (Esteller, 2008). The
reason why these observations are of immense interest is because, unlike mutations, DNA
6

methylation and histone modification are reversible changes. It is possible to reverse the changes
that influence cancer cell behavior by re-expressing the DNA-methylated genes in cancer cell
lines (Esteller, 2008). This is typically done through de-methylating agents that can restore the
original functionality (Esteller, 2007; Herman and Baylin, 2003; Yoo and Jones, 2006).
Recent seminal works have described hallmark characteristics that all cancer types share
due to being driven by the buildup of genetic mutations (Hanahan and Weinberg, 2000, 2011) as
well as how epigenetic regulatory mechanisms are disrupted in cancer cells (Baylin and Jones,
2011; Sandoval and Esteller, 2012). Collectively, these works have firmly established cancer as a
polygenic disease (Banwait and Bastola, 2016): it is the result of genetic abnormalities (i.e.,
mutations) that lead to the upregulation of oncogenes and the inactivation of tumor suppressor
genes but can also be the result of epigenetic factors that may stem from activities that lie outside
the genetic realm (e.g., drugs, viruses, etc.). Among the numerous cancer tissues that have been
extensively studied since its inception, this paper examines the pathology of colorectal
carcinoma.
The Pathology of Colorectal Carcinoma
Colorectal carcinoma (CRC) is the second leading cancer killer and the third most
common cancer diagnosed in the United States (CDC, 2014; National Cancer Institute, 2016).
Diagnosis of CRC is usually done by performing an endoscopic biopsy or polypectomy followed
by microscopic examination of neoplastic cells, after which invasive carcinoma can sometimes
be recognized (Fleming et al., 2012). The definition of invasive carcinoma is restricted to the
submucosal invasion of the colorectum (Fleming et al., 2012). Analysis of submucosal invasion
reveals that most colorectal adenocarcinomas are derived from precursor lesions (i.e., abnormal
damage or change in tissue). Common precursor lesions are adenomas, dysplasia, and serrated
polyps (Fleming et al., 2012).
It is well documented that CRC initially starts out as a polyp, called an adenoma, which is
a benign tumor composed of epithelial cells that can develop into CRC (Vogelstein et al., 2013;
Sears and Garrett, 2014) and may form on the inner wall of the intestine (Cooper et al., 2010).
Endoscopic studies show that adenomas can be either pedunculated or sessile (Fleming et al.,
2012). Adenomatous cells are characterized by their enlarged, hyperchromatic, and elongated
nuclei. Under regular conditions, they are classified into three categories based on their structural
7

components: tubular, tubulovillous, and villous (Fleming et al., 2012). Tubular adenomas are
made up of crypt-like dysplastic glands. Villous adenomas resemble finger-like projections.
Tubulovillous adenomas are intermediate lesions (Fleming et al., 2012).
Serrated polyps describe any polyp that exhibits a saw tooth or star-shaped structure in
epithelial cells (Fleming et al., 2012). Four types of lesions fall into this category: hyperplastic
polyp (HP), sessile serrated adenoma/polyp (SSA/P), and traditional serrated adenoma (Fleming
et al., 2012). Among all four, HPs are the most common. They are found in the distal colon and
are roughly < 5 mm in size (Fleming et al., 2012). SSA/Ps are often seen in the proximal colon
and are generally larger than HPs (Fleming et al., 2012). Although traditional serrated adenomas
are unique and exhibit low grade nuclear dysplasia, their structure is similar to HPs and SSA/Ps
(Fleming et al., 2012). Furthermore, polyps that become cancerous are called adenocarcinomas.
More than 90% of adenocarcinomas are known to originate from epithelial cells of the colorectal
mucosa while the minority of CRC types include neuroendocrine, squamous cell,
adenosquamous, spindle cell, and undifferentiated carcinomas (Fleming et al., 2012).
The quest to understand the molecular pathogenesis of CRC revealed a step-by-step
explanation of how normal colonic tissues progresses to CRC based on key mutations in
oncogenes and tumor suppressor genes that possess critical regulatory and/or repair functions
was proposed (Fearon and Vogelstein, 1990; Hisamuddin and Yang, 2006). In this model, it was
suggested that alterations in either category as well as those resulting from epigenetic
mechanisms (e.g., methylation) drives the tumorigenesis of colonic tissues, pushing it from one
stage to the next (Fig. 2). These genes are called “driver” genes where mutations that occur in
these genes are called “driver” mutations. The term, “driver”, is used to define changes in genes
that either directly or indirectly contribute to the proliferative potential of cells (Vogelstein et al.,
2013). Subsequent studies have identified certain driver genes that are consistently correlated
with the progression of CRC. Among these genes, the most common ones are adenomatous
polyposis coli (APC), a tumor suppressor gene, and KRAS, a proto-oncogene (Fearon, 2011; The
Cancer Genome Atlas Network, 2012; Seshagiri et al., 2012). These studies have suggested that
certain genes may participate in very important processes that make them more valuable to
cellular stability than other genes when evaluating the genetic pathogenesis of CRC. Thus,
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researchers have developed models of CRC to elucidate the mechanisms that encourages the
driver potential of key genes.

Figure 2. The molecular paradigm of colorectal cancer. The first step in CRC progression is
believed to be the formation of aberrant crypt foci (ACF) caused by mutations in the APC and βcatenin gene that lead to the inactivation of APC. The eventual progression to adenoma and
carcinoma stages are typically caused by mutations that activate oncogenic properties in the
KRAS gene and the loss of p53 (i.e., TP53), respectively. Other genes, such as MSH2, MLH1,
PMS2, etc., may contribute to the developmental stages of ACF to advanced adenomas through
epigenetic mechanisms (Hisamuddin and Yang, 2006; Roper and Hung, 2013; Markowitz and
Bertagnolli, 2009).
Human genetic-based models of CRC explain how normal hyperplastic epithelium cells
undergo molecular alterations in multiple genes which cause the development of these cells to
progress onto an adenoma and then toward adenocarcinoma (Sears and Garrett, 2014). The
growth of colonic epithelial cells (CECs) may be determined by the mutations in genes that
influence adenoma and adenocarcinoma (i.e., driver mutations) (Sears and Garrett, 2014). These
mutations may also reduce their vulnerability to apoptosis, causing them become more
specialized in their metabolic processes, and gain control over immunological functions to
further promote metastasis (i.e., spread of cancer from one organ and/or tissue to another) (Sears
and Garrett, 2014).
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A common anatomical location for adenocarcinomas is the human colon, which houses
the largest number of microbes (Sears and Garrett, 2014). Therefore, understanding the role of
microbes, specifically bacteria, in CRC has generated immense interest in the scientific
community. As a derivative of the generic cancer paradigm, colorectal cancer is, at its core, a
heterogeneous group of diseases that encompass unique genetic and epigenetic backgrounds
(Fleming et al., 2012). It is therefore crucial to explore the molecular pathology that underscores
its progression in conjunction with the impact of microbiota conceptual frameworks to properly
evaluate its carcinogenesis (Sears and Garrett, 2014).
Intestinal Microbial Influence on Colorectal Tumorigenesis
Although it is known that buildup of oncogenic mutations over time causes CECs to
replicate uncontrolled – a process that is said to take 10-40 years – it is not known what exactly
causes this gradual change. However, the microbiome is a top suspect for triggering the initiation
and/or progression of colorectal carcinogenesis due to the fact that colonic tissues are the
repositories of the largest and most complex community of microorganisms (Sears and Garrett,
2014). The microbiome is a vast, complex, and dynamic conglomerate of microorganisms that
colonizes the human body, constituting roughly 90% of all the cells (Qin et al., 2010).
Furthermore, it is suspected that the number of microbial genes far supersedes the number of
human genes by 100 times or more. However, many of these microbes that make up the
microbiome do not all contribute to disease but are instead there for the benefit of the individuals
they inhabit.
Healthy microbiomes are directly tied to host benefits while disturbances, natural and/or
artificial, may lead to diseases. Thus, interactions between microbes and their hosts play crucial
roles in maintaining human health (Costello et al., 2012). These interactions are classified into
three general categories: symbiosis, commensalism, and pathogenicity (Hooper and Gordon,
2001). Symbiosis corresponds to a relationship between two different species where one of them
benefits without harming the other (Hooper and Gordon, 2001). Commensalism corresponds to a
relationship where both species coexist without any harm but also without any obvious benefit as
well (Hooper and Gordon, 2001). Pathogenicity refers to a pathogenic relationship whereby the
host is harmed by the host-microbe interaction (Hooper and Gordon, 2001).
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From an ecological perspective, a healthy microbiome is contextualized within ecologic
stability (Bäckhed et al., 2012) that comes with multiple benefits such as extracting nutrients that
are normally inaccessible from dietary substances, encouraging differentiation of host tissues,
stimulation of the immune system, and host protection from invasion by pathogens (Costello et
al., 2012). Furthermore, the balance between beneficial and harmful chemical conversion
reactions that take place in the gut microbiota is determined by its specific composition (Bäckhed
et al., 2012). The reverse is also true where secretion of cytokines (i.e., cell signaling molecules)
and defense effector molecules by host immune system shapes the microbiota community and
promote mucosal immunity (Bäckhed et al., 2012).
Natural disturbances of the microbiome include age, geographical location, host
genotype, probiotics (Bäckhed et al., 2012), environmental selection, and demographic
stochasticity (i.e., ecological drift) (Costello et al., 2012). Artificial disturbances include
extrinsic factors such as inflammation (Costello et al., 2012), intake of food supplements and
drugs (e.g., antibiotics), human diet, and stress (Bäckhed et al., 2012). For example, excess
exposure to antibiotics can disrupt the host-microbe interactions that contribute to human health,
ultimately leading to various diseases such as obesity, type I diabetes, inflammatory bowel
disease, asthma (Bäckhed et al., 2012), as well as acute and chronic disorders such as
malnutrition, necrotizing enterocolitis, and antibiotic-associated diarrhea (Costello et al., 2012).
These disturbances, whether natural or artificial, have elicited the attempt of associating
individual bacterial microbes to human disease. For example, Streptococcus mitis,
Staphylococcus epidermis, Bacillus sp., Mycoplasma sp., and Chlamydophila pneumonia have
all been identified in lung cancer cells (Cummins and Tangney, 2013). Robinsoniella peoriensis,
Pedioccoccus acidilactici, Leuconostoc lactis, and L. mensenteroides have all been identified in
pancreatic cancer cells (Cummins and Tangney, 2013). Staphylococcus epidermis and
Mycoplasma sp. have been identified in breast cancer cells (Cummins and Tangney, 2013).
Ralstonia insidiosa, Fusobacterium naviforme, and Prevotella sp. have all been identified in oral
cancer cells (Cummins and Tangney, 2013). Salmonella typhi, Helicobacter pylori, H. hepaticus,
and H. bilis have all been identified in gall-bladder cancer cells (Cummins and Tangney, 2013).
Chlamydia trachomatis and Mycoplasma sp. have been identified in ovarian cancer cells
(Cummins and Tangney, 2013). These bacteria species have been associated or defined as being
11

causative agents of cancers, further underlining the importance of studying bacterial microbes
and its role in human diseases.
Researchers have developed murine disease models that support the idea that the
microbiota contributes to colon carcinogenesis, but such models weakly illustrate human disease
development (Sears and Garrett, 2014). Three models have been proposed in an attempt to
provide a framework that not only strongly illustrates human disease development but does so
within the framework of microbiota and certain members as either primary (i.e., initiators) or
secondary (i.e., promoting growth) indicators that influence human CRC pathogenesis (Fig. 3)
(Sears and Garrett, 2014). The first model suggests that individual microbes initiate or promote
the growth of CRC. The second model theorizes that there is a collective microbial community
that together initiate or promote the growth of CRC. The last model adopts the idea that single
microbes interact with the microbial community which in turn drives the initiation or promotion
of CRC growth (Sears and Garrett, 2014).

Figure 3. Microbial contributions to the pathogenesis of CRC. The three models summarize the
emerging school of thought that the microbial community is a prime suspect for the underlying
influence of CRC over long periods of time (Sears and Garrett, 2014).
Numerous suspected bacteria species have warranted possible identification of being
causative agents or bacterial drivers of colorectal cancer, where they may possess carcinogenic
features that may promote or initiate the disease. Many of these organisms have been identified
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through metagenomics analysis where the 16S rRNA amplicons (i.e., a segment of DNA or RNA
to be amplified) obtained from tumor and matching non-tumor samples in patients with CRC
have been used to generate microbiome maps in order to identify microbes (Tjalsma et al., 2012;
Marchesi et al., 2011; Kostic et al., 2012; Castellarin et al., 2012). A recent study took advantage
of metagenomics methods to identify bacteria organisms from 130 matching tumor and nontumor samples in 65 CRC patients. The results reveal that organisms within three genera have
been found to demonstrate significant co-occurrence within individual colorectal tumor cells
where they collectively illustrate a metagenomic signature of CRC: Fusobacterium,
Campylobacter, Leptotrichia, and Selenomonas sp. (Warren et al., 2013). This was done by
performing a read-pair alignment analysis where each of the bacterial sequences ran against
sequence databases of human rRNA, bacterial, and viral RefSeq genome sequences using the
Burrows-Wheeler Aligner for human sequences and Novoalign for bacterial and viral sequences
(Warren et al., 2013). This allowed the determination of which species were significantly overrepresented in colorectal tumor cells. Metagenomics analysis revealed that F. nucleatum, C.
showae, L. hofstadii, L. buccalis, and S. sputigena had an over-representation of mapped read
pairs that were of tumor origin (Fig. 4) (Warren et al., 2013).

Figure 4. Microbial abundance in CRC and normal gut mucosa tissue via RNA-seq. A)
Phylogenetic abundance gathered from unique metatranscriptomics read pair mapping. B)
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Distribution of species uniquely mapped to Fusobacterium, Campylobacter, Leptotrichia, and
Selenomonas normalized sequence pairs (Warren et al., 2013).
Between the two Leptotrichia species, it can be seen that L. hofstadii has the higher readpair alignments. However, since both strains were isolated from colorectal tumor cells with very
similar numbers of unique read-pair alignments, it is not known which one of the two species can
facilitate stronger interactions with F. nucleatum, C. showae, and S. sputigena in the
development of colorectal tumors. This is because it is also possible that all five strains work
together to promote tumorigenesis. All five bacteria are gram-negative anaerobes that participate
in a commensalism relationship with the oral cavity, specifically, the subgingival plaque (Etoh et
al., 1993; Macuch and Tanner, 2000). Furthermore, the study shows that Fusobacterium,
Campylobacter, and Leptotrichia sp., when isolated from tumor tissue, co-aggregated in culture
(Warren et al., 2013). While co-aggregation is not uncommon in microbial co-cultures given the
fact that they occupy the same niche, prior studies have shown that co-aggregation of F.
nucelatum and Streptococcus cristatus increases F. nucleatum’s ability to invade into cultured
host cells as well as altering the host response to it (Edwards, Grossman, and Rudney, 2006;
Zhang, Chen, Rudney, 2011). Additionally, prior studies have shown that co-aggregation of F.
nucleatum with other species facilitated the survival of obligate anaerobes (i.e., an organism that
cannot tolerate any oxygen) in aerated environments (Bradshaw et al., 1998).
F. nucleatum has been repeatedly linked with CRC in multiple studies (Casellarin et al.,
2012; Kostic et al., 2012; McCoy et al., 2013). It is a pro-inflammatory anaerobe that is invasive,
adherent, and known to be associated with other diseases such as periodontitis (Han et al., 2000;
Signat et al., 2011; Swidsinski et al., 2009). Morphological studies have revealed that the
organism is a small spindle-shaped rod and, in addition to being gram-negative, is non-spore
forming and non-motile. Most of the cells are between 5 to 10 µm with sharply pointed ends
(Bolstad, Jensen, and Bakken, 1996). While F. nucleatum is indeed an anaerobe, studies show
that it can grow in an environment of up to 6% oxygen (i.e., a facultative anaerobe) (Moore et
al., 1984).
Although a member of the order Fusobacteriales by virtue of being part of the
Leptotrichiaceae family, little is known of the pathogenic potential of L. buccalis (Warren et al.,
2013). Previous studies have shown that this gram-negative, rod-shaped (Bernard et al., 1991)
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anaerobe was found in patients with lymphoma and leukemia. However, it is not known whether
L. buccalis played a causative role in the development of cancer as these patients are
immunocompromised and therefore more susceptible to bacterial infection (Warren et al., 2013;
Eribe and Olsen, 2008; Weinberger et al., 1991). Although classified as an obligate anaerobe
(Grollier et al., 1990), it has been proven that some strains of L. buccalis are capable of being
aero-tolerant having grown well in 5% CO2 atmosphere (Clark et al., 1984, Bernard et al., 1991).
However, to what extent the bacterium is aero-tolerant remains unclear. Like its fellow
Fusobacterium brethren, it is also non-motile as evidenced by the absence of flagella (Warren et
al., 2013).
Like many of its fellow siblings in the family, C. showae is known to play pivotal roles in
intestinal diseases such as Crohn’s disease (Allos and Blaser, 1995; Maher et al., 2003; Tay et
al., 2013), as well as being associated with gingivitis, periodontitis, and cholangitis (Macuch and
Tanner, 2000; Etoh et al., 1993; Suzuki et al., 2013). It is a gram-negative, straight rod organism
that possesses multiple unipolar flagella, making it a motile anaerobe. Although the bacterium
prefers to grow in an anaerobic environment, it can grow under microaerophilic conditions (Etoh
et al., 1993). Size of bacterium cells are 0.5 to 0.8 µm wide and 2 to 5 µm long with round ends.
It has two to five unipolar unsheathed flagella as well (Etoh et al., 1993). Although C. showae
has been suspected of having a causative link to diseases, its pathogenicity is unknown (Etoh et
al., 1993; Suzuki et al., 2013).
Traditionally found in the upper respiratory tract, S. sputigena is an anaerobic gramnegative curved rod organism. However, like C. showae, the presence of a flagella points the fact
the bacterium is motile (McCarthy and Carlson, 1981). Although studies have shown that S.
sputigena may be implicated in the pathogenesis of generalized aggressive periodontitis, the
exact causative link remains to be seen (Goncalves et al., 2012). Furthermore, while S. sputigena
was found to be the least significant out of the four overrepresented species, previous studies
have shown co-aggregation between the bacterium and F. nucleatum (Kolenbrander, Andersen,
and Moore, 1989) backed by a high correlation value (Warren et al., 2013). This warrants the
need to investigate the causative link between S. sputigena and CRC.
To this end, the possibility that Fusobacterium, Campylobacter, Leptotrichia, and
Selenomonas sp. may have an etiological role in the development of CRC where the interaction
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between the species could promote or induce significant molecular changes of colorectal tumor
cells is the subject of this paper. This proposition will be explored using cancer cell lines to
explore the relationship between CRC and bacterial biofilm growth of F. nucleatum, C. showae,
L. buccalis, and S. sputigena.
Bioinformatics Approaches in Evaluating CRC
Although cancer research has relied on traditional methods for decades, the sole use of
these methods have become woefully insufficient to solve and understand the ever increasing
complexities of cancer biology. Bioinformatics approaches have played prominent roles in the
identification and validation of biomarkers, developing clinical phenotype profiles that are
patient-specific, and providing ways to measure disease progression as well as response to
therapy (Wu, Rice, Wang, 2012). For example, by using databases such as Gene Ontology (GO)
(Ashburner et al., 2000) to extract data on biological processes or Kyoto Encyclopedia of Genes
and Genomes (KEGG) (Kanehisa and Goto et al., 2000) to obtain information on biological
pathways, one can better understand the biological function of various molecules (e.g.
microRNAs (miRNAs)) and their targets (e.g. mRNAs). GO is a database that encompasses a
wealth of information on the roles of genes and gene products in many organisms (Ashburner et
al., 2000). KEGG is a database that is often used to link information between the genes present
in genomes and a network of interacting cellular components to produce pathways that represent
higher order biological functions (Kanehisa and Goto et al., 2000). The information contained
within the two databases can then be used to construct a model that represents the interplay
between a cell’s molecular state and its response to anti-cancer therapy for a specific cancer type
(Wu, Rice, Wang, 2012).
In addition to the use of databases, there are numerous algorithms and software programs
designed with the intent of analyzing complex cancer data. These techniques take advantage of a
variety of things such as sequence homology to identify miRNA families that play a role in
cancer and then use these miRNAs to identify gene targets such as transcription factors, secreted
factors, receptors, and transporters by tracking what these miRNAs bind to (Lim et al., 2003,
2005; Grosshans et al., 2005, Krek et al., 2005). Other bioinformatic approaches take advantage
of pooling in multiple tools that individually analyze different aspects of a complex cancer
dataset and then provide results that are used to understand how a particular process is frequently
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perturbed in cancer progression (Beck et al., 2014). It can also be used to discover novel models
that lead to more efficient ways to understand a perturbed process (Roca et al., 2014). These
tools serve as a massive framework that provides a powerful way to infer conclusions and
implications on how perturbed processes work and develop strategies to counteract it.
Thesis Approach
This framework serves as an integral part in the investigation of microbial impact on
CRC. The intent is to use software programs visualize how the bacteria species interact with
CRC cells to study the dynamic interplay between bacterial biofilms and CRC cells which
explain how one affects the other and vice versa. In evaluating this interplay, the paper focuses
on three key software programs that were used in the project: ImageJ, Comstat2, and Icy.
ImageJ (Fig. 5a) is an open-sourced imaging program written in Java that is capable of
reading many image formats commonly used in the biomedical sciences (Abramoff, Magalhaes,
and Ram, 2004). It has many different operations such as reading and writing image files,
convolution, edge detection, Fourier transform, histogram, and particle analyses (Abramoff,
Magalhaes, and Ram, 2004) – just to name a few. It also allows users to write macros and
plugins in different languages although most of them are written in Java. Macros are scripts
meant to expand a single task, making it easier to automate it for repeated tasks while plugins are
external programs that arm ImageJ with unique capabilities the program does not have
(Abramoff, Magalhaes, and Ram, 2004). Finally, the program can run on any operating system
and can be integrated into other software programs.
Comstat2 (Fig. 5b) is a graphical user interface derivative of the original Comstat. This is
a novel, open-sourced, computer program that analyses three-dimensional biofilm structures
using a host of parameters designed to quantify it (Heydorn et al., 2000). 3D images of bacterial
biofilm are typically attained through confocal microscopy experiments where they can be
opened up by an imaging software, such as ImageJ, and then analyzed using the ten parameters.
Comstat2 can exist within the ImageJ platform as a plugin to be used whenever the user desires
(Fig. 5c). The program can also exist as a standalone program via the utilization of a JAR file
(i.e., a runnable software by aggregating different Java class files). This allows users to analyze
quantifiable data of biofilms using Comstat2 without the need to have or understand the
underlying computer language skills.
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Figure 5. Screenshots of ImageJ and Comstat2 software. (a) ImageJ main window opened using
Microsoft Windows OS. (b) Comstat2 opens up three pop-up windows. The top-left opens the
window that lists all the folders that contains the correct image files Comstat2 looks for in the
directories. The bottom-left show the log screen which records every action taken in the software
(top) and the PATH location to each directory opened up (bottom). The window on the right
contains the list of parameters that users can choice to analyze 3D biofilm structures. (c) ImageJ
plugin menu to open the Comstat2 software.
Icy is an open-source platform for bioimage informatics that is used analyze biological
images (de Chaumont et al., 2013). Similar to ImageJ, it has an extensive plugin library. One of
the most prominent features is the visualization of 3D data, which is performed using
Visualization Toolkit (VTK) (Fig. 6). VTK is an open-source software routinely used in 3D
computer graphics and is written in several combined programming languages such as C++,
Java, and Python (http://vtk.org). Icy is completely written in Java although some of the plugins
can be written using JavaScript and Python (de Chaumont et al., 2012). Furthermore, Icy
natively integrates the ImageJ platform where Comstat2 can be used as an internal ImageJ
plugin.
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Figure 6. Screenshot of Icy interface. The above images show what Icy looks like when the user
opens it up. The ImageJ platform is accessible by virtue of a tab with its own name and contains
every plugin of its own. Users can also add their own plugins by creating a JAR file and then
embedding it into the software. The same goes for Icy-based plugins as well.
Thesis Goals
In evaluating the impact of anaerobic bacteria on colorectal cancer, this thesis project has
four distinct goals. The first is to firmly establish the ability of F. nucleatum, C. showae, L.
buccalis, and S. sputigena to produce biofilms – a known contributor to disease. The second is to
explore how bacterial biofilm production impacts the growth of CRC cells by assessing cellular
viability. The third is to explore how bacterial biofilm production and establishment is influenced
when growing in presence of CRC cells. The last goal of this project is to further explore the
relationship between anaerobes and CRC by evaluating the progression of normal epithelial
colorectal cells through miRNA sequencing analysis.

M ETHODS
Reconstitution of lyophilized bacteria cultures and growth conditions
Lyophilized cultures of Leptotrichia buccalis (ATCC 14201), Fusobacterium nucleatum
(ATCC 25586), Campylobacter showae (ATCC 51146) (ATCC, Manassas, VA), and
Selenomonas sputigena (ATCC 35185) (ATCC, Manassas, VA) were reconstituted precisely
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according to the manufacturer’s instructions and subsequently inoculated aseptically onto the
surface of CDC-formulated blood agar plates (VWR, Pittsburg, PA) using the quadrant streak
method. The plates were then incubated at 37oC for 48 hours in an AS-500 anaerobic chamber
(Anaerobe Systems, Santa Clara, CA) under anaerobic conditions (90% N2, 5% H2, and 5%
CO2). Multiple liquid pure cultures of each bacterial species was prepared by aseptically
inoculating a single isolated colony into a screw-capped Hungate glass tube which contained 10
mL of sterile, pre-reduced anaerobic broth composed of brain-heart infusion (BHI) medium
reconstituted within liquid dental transport medium (LDT; Anaerobe Systems, Santa Clara, CA).
All tubes were incubated for 48 h at 37oC under anaerobic conditions.
Preparation of bacteria -80oC glycerol stocks
Cryopreservation of bacteria isolates used in this study was achieved by aseptically
preparing and subsequently storing multiple tubes of 20% glycerol bacterial stocks at -80ᵒC.
Briefly, a day prior to preparing the glycerol stocks, a rack of sterile internally threaded
cryopreservation tubes (Corning, Corning, NY) were placed into the anaerobic chamber
(Anaerobe Systems, Santa Clara, CA) and the caps were slightly but carefully loosened. A bottle
of glycerol was heat sterilized under standard autoclaving conditions and was immediately
placed into the anaerobic chamber with the top slightly loosened to allow the gaseous anaerobic
environment to permeate the glycerol in the tubes as they cooled. The following day, 200 µL of
sterile pre-reduced glycerol was aseptically pipetted into several sterile pre-labelled
cryopreservation tubes, followed by the addition of 800 µL of bacteria culture. Multiple tubes of
each bacteria isolates was similarly prepared with subsequent complete mixing by inversion
while in the AS 500 anaerobic chamber before being stored at -80oC.
Bacterial biofilm viability
A 1:200 dilution of the bacterial isolates was prepared in LDT + BHI medium and 200
µL of this dilution was seeded into the wells of a 96-well plate and incubated in 5% CO2
humidified anaerobic and microaerophilic environments at 37oC for 3 days using GasPakTM EZ
Anaerobe Container System (BD Diagnostics; Sparks, MD) and GasPakTM EZ Campy Container
System (BD Diagnostics; Sparks, MD), respectively. Following the incubation period, 100 µL of
a 0.01% crystal violet solution was added to the wells and the wells of each plate were allowed
to sit for 20 min with gentle agitation every few minutes. After excess crystal violet was
discarded by grasping the plate and applying an almost simultaneous yet quick inversion and
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sharp/abrupt stoppage of a forward movement, each plate was gently washed two times using
300 µL of water and subsequently allowed to air-dry. The crystal violet-stained biofilm was
subsequently immersed in 200 µL of absolute ethanol and allowed to sit for 20 min. Indirect
biofilm formation data was acquired by reading the absorbance values of each well using a 96well spectrophotometer at 595 nm. Softmax Pro (Molecular Devices, Sunnyvale, CA) software
was used to capture the data, however, the data was visualized using the graphing features
present in Microsoft Excel (Microsoft; Seattle, WA).
Cell culture of HCT116 cells
Upon receipt, the colon cancer cell line HCT116 (ATCC CCL-247) (ATCC, Manassas,
VA) was immediately thawed with gentle agitation in a 37oC water bath according to exact
instructions provided by the ATCC. Thereafter, the cell line was cultured in McCoy’s 5A
medium (Iwakata and Grace Modification) with L-glutamine (Catalogue #45000-374; VWR,
Randor, PA) supplemented with 5% fetal bovine serum (FBS) (Catalogue #10437010, Gibco by
Thermo Fisher Scientific Inc., Waltham, MA) in 75 cm2 Corning T-75 flasks (Product #43725U;
Corning, NY) as described by the manufacturer. The cell line was grown at 37oC in a humidified
environment of 5% CO2 in air atmosphere until cells reached 70-80% confluency with medium
renewal every 2-3 d. Cryopreservation of HCT116 cells was achieved by preparing liquid
nitrogen stocks in cryopreservation medium that contained a mixture of 50% FBS (Catalogue
#10437010, Gibco by Thermo Fisher Scientific Inc., Waltham, MA), 40% culture medium, and
10% Synth-a-Freeze (Catalogue #A13713-01; Cell Therapy Systems by Thermo Fisher Scientific
Inc., Waltham, MA). This was then used to produce 1 mL aliquots of cell culture and was stored
at -80oC.
Confocal analysis of bacteria biofilms grown under anaerobic and microaerophilic
conditions
Prior to confocal image analysis, biofilm from each bacteria isolate was grown in a 24mm glass dish with 2 mL of LDT + BHI medium over a period of four days to one week in
anaerobic and microaerophilic environments using GasPakTM EZ Anaerobe Container System
(BD Diagnostics; Sparks, MD) and GasPakTM EZ Campy Container System (BD Diagnostics;
Sparks, MD), respectively. Both groups of samples were maintained at 37oC in a humidified 5%
CO2 atmosphere. The medium was not replaced during the growth cycle. After aseptically
removing the medium, biofilm formation from the bacterial isolates was stained with
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Invitrogen’s LIVE/DEAD Biofilm Viability Kit (Thermo Fisher Scientific Inc., Waltham, MA)
as directed by the manufacturer. Specific areas of each sample was scanned using the Leica TCS
SP5 II (Leica Microsystems; Wetzlar, Germany) software for biofilm structures using water
immersion lens at 40X magnification. The images were obtained through the generation and
image capture of z-stacks. The number of z-stacks obtained and the thickness of each slice was
dependent upon biofilm thickness, composition and the type of organisms used. Each image slice
was acquired with a resolution of 1024 x 1024 pixels.
Confocal analysis of HCT116 cells
Prior to confocal microscopic analysis, each sample was first grown in a 24-mm glass
dish with 2 mL of appropriate medium over a period of one week in a microaerophilic
environment using the GasPakTM EZ Campy Container System (BD Diagnostics; Sparks, MD).
The medium was not replaced during the growth period. After aseptically removing the medium,
the samples were each stained with Invitrogen’s LIVE/DEAD Biofilm Viability Kit (Thermo
Fisher Scientific Inc., Waltham, MA) and Life Technologie’s NucBlue Live ReadyProbes
Reagent (Thermo Fisher Scientific Inc., Waltham, MA) according to exact instructions by
manufacturer. Briefly, one to two drops of the NucBlue stain was added to each well of cell
growth followed by confocal microscopy. Specific areas of each sample was scanned using the
Leica TCS SP5 II (Leica Microsystems; Wetzlar, Germany) software for biofilm structures using
water immersion lens at 40X magnification. Images were obtained via z-stacks with slices taken
at 3.8 µm thickness per slice for a total of 43 slices and a resolution of 1024 x 1024 pixels.
Confocal analysis of co-cultured HCT116 cells and bacteria
Prior to confocal microscopic scanning, HCT116 cells were grown in 24-mm glass dish
wells with 2 mL of appropriate medium. Cells were allowed to grow over a period of one week
in a microaerophilic environment using the GasPakTM EZ Campy Container System (BD
Diagnostics; Sparks, MD) with no medium renewal during growth period. After one week, 1 mL
of bacteria samples was added to each well, with each well receiving one of the four bacteria
species and subsequently allowed to grow for 24 h. Following 24 h growth period, the medium
was aseptically removed and the samples were stained with Invitrogen’s FilmTracer Biofilm
staining Kit (Thermo Fisher Scientific Inc., Waltham, MA) and NucBlue Live ReadyProbes
Reagent (Life Technologies by Thermo Fisher Scientific Inc., Waltham, MA) as directed by the
manufacturer. Specific areas of each sample was scanned using the Leica TCS SP5 II (Leica
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Microsystems; Wetzlar, Germany) software for biofilm structures using water immersion lens at
40X magnification. The images were obtained via z-stacks. Number of z-stacks obtained and
size of each slice was dependent on the composition and type of organisms used. Each image
was acquired with a resolution of 1024 x 1024 pixels.
3D construction of images using Icy
Images generated by confocal microscopy were visualized using a collaborative bioimage
informatics platform called Icy (Pasteur Institute; Paris, France). Images were extracted from
“.LIF” files and opened up in the navigator. 3D reconstruction of images was done by switching
visualization mode to 3D VTK option. After adjusting parameters to get desired images, they
were then saved by taking a screenshot of the screen and then cropping regions of interest.
Computational analysis of biofilm images using Comstat2
Prior to Comstat2 (v2.1; SEAS-NVE A/S, Denmark) analysis, TIFF image stacks of
biofilms produced by Leica TCS SP5 II (Leica Microsystems; Wetzlar, Germany) were
converted to single OME-TIFF files using the LOCI tools built in Comstat2 (v2.1; SEAS-NVE
A/S, Denmark) in greyscale according to the exact instructions provided by the COMSTAT 2.1
Manual. Predetermination of threshold values for each OME-TIFF file was done by using
automatic (Otsu’s method) thresholding in the Comstat2 (v2.1; SEAS-NVE A/S, Denmark)
control panel. Computational analysis of OME-TIFF image files was performed by Comstat2
(v2.1; SEAS-NVE A/S, Denmark) according to the following parameters: Biomass, Thickness
Distribution, and Surface Area. From the surface area parameter, average surface area and
surface to volume ratio was calculated. Numerical data was produced in the form of a text file,
which was opened using Microsoft Excel 2016 (Microsoft; Seattle, WA).
Viability of HCT116 cells and bacteria using ImageJ
Images obtained from confocal microscopy were used to assess viability of cells and
bacteria. This was done by first using ImageJ’s split channels function under Image → Color tab
to split the images into two channels for samples stained using Invitrogen’s FilmTracer
LIVE/DEAD Biofilm Viability Kit (Thermo Fisher Scientific Inc., Waltham, MA) to distinguish
between image channels stained green (LIVE) and red (DEAD). Images stained with the
additional NucBlue Live ReadyProbes Reagent (Thermo Fisher Scientific Inc., Waltham, MA)
for co-cultured growth of HCT116 cells and bacteria were split into three channels where the
first one was stained blue (nucleus) with the second and third channels stained red and green,
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respectively. To figure out which stain was used for each channel, ImageJ’s Subtract
Background function under Process → Subtract Background was used. Before calculating
cellular and bacteria viability, the images were cleaned up by first changing the colors to black &
white under Image → Adjust → Threshold. This was followed by changing the color to B&W
and then clicking Apply. Subsequently, the background was filled by clicking the Fill Holes
option under Process → Binary → Fill Holes. The background colors were then inverted by
using the Convert to Mask option under Process → Binary → Convert to Mask. Finally, using
the Watershed option under Process → Binary → Watershed, the images were automatically
segmented to cut particles that were touching each other. Cellular viability was counted using the
Analyze Particles under Analyze → Analyze Particles. To separate cells from bacteria species in
the images, the size and circularity was adjusted.
Statistical analysis
Examination of the differences between HCT116 cells grown in the presence of vs. the
absence of bacterial biofilms was tested with the nonparametric Mann-Whitney U test using the
R statistical language (https://www.r-project.org/). Statistical significance was determined by
comparing the viability of HCT116 cells grown in the absence of bacteria vs. presence of
bacteria.

RESULTS
Confocal microscopy was performed on samples composing of individual and collective bacteria
species. Each sample was grown in anaerobic and microaerophilic environments. The 2D images
portray a snapshot of the live (green) / dead (red) organisms that are present in the biofilm. In
addition to viability composition, the general organization from the top of the biofilm can be
deduced as well. Images were taken at 40X magnification.
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Figure 7. 2D confocal images of bacterial cultures in (1) anaerobic vs. (2) microaerophilic
environments. (A) F. nucleatum. (B) C. showae. (C) L. buccalis. (D) S. sputigena. (E) All four
together. These images were obtained using the ImageJ software. What is notable in each image
is the difference in organization and overall morphological formation of biofilm structures grown
in the two environments.
Each image generated from confocal studies was then extrapolated in a 3D structure using Icy.
Once opened up in the software, the color parameters were adjusted to generate optimal 3D
images. The 3D perspective provides more information about the overall biofilm structure,
viability, as well as much more prominent composition of clusters and voids.
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Figure 8. 3D biofilm images of anaerobic microbes grown in (1) anaerobic and (2)
microaerophilic environments. (A) F. nucleatum. (B) C. showae. (C) L. buccalis. (D) S.
sputigena. (E) All four together. These images were obtained using the Icy software. Similar to
the results obtained in Figure 7, the overall biofilm structure can be seen to determine how the
microbes organized themselves by either clustering around certain areas as well as present a
visual ratio of viable (green) vs. non-viable (red) anaerobes.
Crystal violet biofilm assay performed on each organism grown in anaerobic and microaerophilic
environments revealed that each anaerobe can produce biofilms.
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Figure 9. Biofilm growth of anaerobes in anaerobic and microaerophilic environments. This
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confirms the ability of each microbe to grow well-established biofilms.
Each confocal image was quantitatively analyzed using Comstat2 using biomass, average,
thickness, surface to volume ratio, and average surface area. The four parameters are used to
assess how the biofilm adapts over time in both environments.

Figure 10. Biofilm parameters of F. nucleatum, C. showae, L. buccalis, S. sputigena, and all four
together grown in anaerobic and microaerophilic environments. (A) Biomass. (B) Average
thickness. (C) Surface to volume ratio. (D) Average surface area. Results were obtained using
Comstat2.
Viability of each organism was directly assessed using ImageJ through the Analyze Particles
option to see how well each organism survived in both environments over a long period of time.

Figure 11. Comparison of live and dead anaerobes in (A) anaerobic and (B) microaerophilic
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environments. Viability results were obtained using ImageJ.
HCT116 samples were scanned by confocal microscopy to generate 2D images. HCT116 adopts
cancerous phenotypic qualities as shown by the elongated fibroblastic-like shapes and rapid
proliferation of cells within a short time period. Images were taken at 40X magnification.

Figure 12. 2D confocal images of HCT116 colorectal carcinoma cells.
2D confocal images of HCT116 samples co-cultured with individual and collective bacteria
species was generated. Composition and limited assessment of bacterial biofilm viability can be
gleaned from each images. Also prominent in images B and D is the apparent struggle of
bacterial biofilm establishment. Images were taken at 40X magnification.

Figure 13. 2D confocal images of HCT116 colorectal carcinoma cells co-cultured with
anaerobic microbes in microaerophilic environment. (A) F. nucleatum. (B) C. showae. (C) L.
buccalis. (D) S. sputigena. (E) All four together.
3D images of each co-cultured sample was generated in Icy and adjusted using the color
parameters to produce optimal images. The breakage of biofilm structures points to the struggle
of bacterial organisms struggling to generate well-established structures when growing in the
presence of HCT116 cells.
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Figure 14. 3D images of HCT116 colorectal carcinoma cells co-cultured with anaerobic
microbes in microaerophilic environment. (A) F. nucleatum. (B) C. showae. (C) L. buccalis. (D)
S. sputigena. (E) All four together.
Each co-cultured sample was quantitatively analyzed using ImageJ’s Analyze Particles option to
provide a direct assessment of live/dead cells. In addition, HCT116 cells grown in the absence of
any bacteria species was assessed as well. Statistical significance was done between viability of
HCT116 cells grown in the absence and presence of individual and collective anaerobes using R.
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Figure 15. Viability of HCT116 cells grown in the absence and presence of anaerobes. The
Mann-Whitney U test was performed for each co-cultured growth compared to single cell
cultured growth experiments to evaluate statistical significance using a p-value cutoff of p <
0.0001. p values for co-cultured experiments of F. nucleatum, C. showae, L. buccalis, and S.
sputigena was p < 2.2 × 10-16 while p = 1.386 × 10-14 for all four together.
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Comstat2 was used to characterized biofilm structures of individual and collective anaerobes
grown in the presence of HCT116 cells.

Figure 16. Biofilm parameters of F. nucleatum, C. showae, L. buccalis, S. sputigena, and all four
together co-cultured with HCT116 cells. (A) Biomass. (B) Average thickness. (C) Surface to
volume ratio. (D) Average surface area.

DISCUSSION
2D (Fig. 7) and 3D (Fig. 8) images of F. nucleatum, C. showae, L. buccalis, and S.
sputigena revealed stark morphological differences of biofilm growth between anaerobic and
microaerophilic environments. Nevertheless, the organisms were capable of producing wellstructured biofilms as evidenced in Figure 9. This was even more prominent upon in-depth
analysis of biofilm characteristics on each microbe grown in both environments (Fig. 10). It is
interesting to note that C. showae initially produced the most biofilm but over time, the other
species catch up and, in the case of F. nucleatum and S. sputigena, surpassed its growth rate.
When comparing the two environments each organism grew in, the initial stage revealed that C.
showae and S. sputigena were more comfortable growing in anaerobic than microaerophilic
while the opposite held true for F. nucleatum and L. buccalis. Upon closer inspection on
individual biofilm growth over long periods of time, S. sputigena was the only organism to grow
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very well in an anaerobic environment compared to microaerophilic. This analysis can be seen in
comparing the biomass parameter across all four individual organisms.
Furthermore, when analyzing other biofilm characteristics such as average thickness and
average surface area, one can use it to understand the overall spatial size of the biofilm and what
percentage of the overall biofilm was exposed to nutrient flow, respectively. Here, it seemed that
for both cases F. nucleatum and S. sputigena did well compared to C. showae and L. buccalis in
both environments. However, it is important to note C. showae produced the thickest biofilm in
microaerophilic environment while S. sputigena produced the thickest biofilm under anaerobic
conditions. These results are interesting when put into the perspective of how well the overall
biofilm was able to extract the nutrients from its environment, one sees that C. showae did very
poorly while S. sputigena did very well. This is surprising because one would reasonably assume
that large biofilms are capable of extracting lots of nutrients but this was only true for S.
sputigena and (to a lesser extent) F. nucleatum. This could mean that C. showae and L. buccalis
were extremely inefficient at extracting nutrients when growing in both environments but further
studies are needed to fortify such conclusions.
Finally, when evaluating the surface to volume ratio, one gets a sense of how the biofilm
adapts to its environment. When comparing all four individual organisms in anaerobic
environments, it becomes clear that F. nucleatum had a hard time adapting to the environment
and thus needed to contract while spreading over a larger area of the substratum (i.e.,
bottommost layer) in order to optimize its access to scarce resources while S. sputigena was the
most efficient in optimizing access to resources. When comparing the anaerobes grown in
microaerophilic environment, S. sputigena was the one that had the hardest time adapting the
environment while L. buccalis had the least burden for environmental adaptability. These results
are interesting because, for one, they almost contradict each other. For example, S. sputigena had
the hardest time adapting to a microaerophilic environment yet it had one of the highest biofilm
mass, overall average thickness, and an extraordinary ability to extract resources from its
surroundings as the biofilm grew larger and larger. Now, one could attribute this to the fact that
it possesses flagella which gives it a significant advantage over organisms that do not but the fact
that it grew very well despite having difficulty adapting to its environment warrants further
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investigation because C. showae not only has flagella but possess multiple flagella as explained
in the introduction yet it did not produce similar consistent results as S. sputigena.
A breakdown of individual organisms grown in anaerobic vs. microaerophilic to their
viability rates revealed a much more precise numerical picture of how well each organism did
within well-established biofilms (Fig. 11). In spite of S. sputigena doing very well in producing
biofilm growth, far more organisms died when grown in either environment. To a lesser extent,
the same was true for the rest of the organisms with the exception of L. buccalis. In fact, when
grown under microaerophilic conditions, L. buccalis had the highest survivability rate compared
to the other three anaerobes. Upon acute analysis, this makes sense given that the organism had
the lowest surface to volume ratio compared to the other organisms.
Further analysis on the survivability of all four anaerobes grown together revealed that
they seem to fare better in anaerobic vs. microaerophilic. From an objective biological
standpoint, this may contribute to the availability of resources that may suddenly seem scarce in
microaerophilic compared to anaerobic environments. The almost complete reversal in
survivability ratios between two environments points to competition for resources between the
species. Another factor to be considered here is the interaction that may occur between the four
organisms. As mentioned earlier in the introduction, co-aggregation of bacteria species has been
known to facilitate survival of organisms that prefer to grow in one environment over another.
Since it is clear from individual bacterial biofilm growth that F. nucleatum and L. buccalis did
very well in microaerophilic over anaerobic – both in the initial stage and in the long term – it
would not be surprising that C. showae and S. sputigena rely on these two species for exchange
of communication and genes to promote their own survival. The reciprocal can also be true
where F. nucelatum and L. buccalis rely on the other two species for movement in the
environment for search of food and optimal areas to maximize growth and survival rates.
However, when analyzing the biofilm characteristics of all four grown together, it is
revealed that they did very poorly across the board. Comparing all four anaerobes grown
together to their individual growth reveals that they had the lowest biomass, average thickness,
and average surface area while having one of the highest surface to volume ratio. This suggests
that although bacteria species may be interacting amongst themselves, these interactions may not
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necessarily be one of a beneficial relationship. It seems that competition among organisms is
intense even in the presence of resources that would ordinarily be abundant.
This competition is further explored when the anaerobes are individually and collectively
grown in the presence of HCT116 cells (Fig. 12). Here, co-cultured experiments in an anaerobic
environment was not necessary because in reality, human beings are aerobic creatures and while
the intestinal tract is generally considered to be anaerobic, the influx of oxygen in and out of the
human body renders the environment microaerophilic due to the consistently basal levels of
oxygen present. Confocal 2D (Fig. 13) and 3D (Fig. 14) images of individual and collective
species grown in microaerophilic environments reveals tremendous information about how the
anaerobes organized themselves as they grew in presence of another entity that was fairly large.
In both dimensional images, one sees a “breakage” among biofilm structures of individual
organisms while there is a uniform and well-establish biofilm structure when all four grow
together. This “breakage” that seems to be prevalent among only individual organisms may
suggest that there was a loss of communication as they struggled to grow fortified biofilms
among resource-hoarding cancer cells that were already vicious and malignant in their behavior
and possess no logical sense of organization.
The microbial impact on CRC is curiously evaluated in Figure 15. To be sure, HCT116
cells co-cultured with each organism – both individual and collective – was deemed statistically
significant when compared to samples that grew in the absence of any bacteria growth. The most
surprising result was the effect of L. buccalis on HCT116 cells. Upon first glance, it would
appear that the growth of L. buccalis on the cells did not have any effect. However, from a
different perspective, one could ponder if L. buccalis possess significant driver genes that not
only promotes the growth of CRC but also increases the viability of growing cells. While one
should indeed take this with a grain of salt given that the organisms were only grown on the cells
for 24 h, these results do indeed warrant further investigation into the specific role that L.
buccalis may play in the progression, proliferation, and viability of CRC. It is unlikely that this is
a fault of the algorithm as it caught a substantial number of dead cells for the other organisms.
The other rather surprising result was the effect that all four bacterial organisms grown
together had on HCT116 cells. It is the only other co-cultured system in which the number of
live cells was greater than the number of dead cells. This is immensely surprising given that the
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number of dead HCT116 cells grown in the presence of individual bacterial organisms – with the
exception of L. buccalis – was higher than the number of live cells. One hypothesis that could
explain these results is that in an environment where HCT116 cells was much more efficient at
getting resources compared to individual bacteria species, the anaerobes could have been
struggling and were thus locked in a deadly battle with these cancer cells. This competition
enhances an already intense and harsh environment, causing the CRC cells to die as time goes
on. But, in an environment where all four organisms are growing together, it could be that all
four organisms have put aside their petty differences and worked together to establish an
effective means of communication that not only creates conditions that are favorable to them but
also encourages CRC cells to grow and survive. This conclusion should not come as a surprise
given the revealing relationship between L. buccalis and HCT116 cells.
These results are further underlined when closely evaluating the relationship between
bacterial biofilms and HCT116 cells (Fig. 16) in which all four of them grown together in the
presence of CRC cells produced the highest amount of biofilm. L. buccalis, quite interestingly,
has the second highest biofilm production, average thickness and average surface area yet the
second highest surface to volume ratio. This suggests that while it struggled to adapt to its
environment, it did so while still being capable of growing well-established biofilms and was
quite efficient at manipulating its biofilm to access available nutrients. Furthermore, F.
nucelatum did fairly well as it had the highest average thickness and the lowest surface to
volume ratio. While this was not surprising given the growing amount of evidence that points to
the relationship between F. nucleatum and CRC, these results do indicate the need to understand
how F. nucleatum affects the pathogenicity of the other three organisms when grown in the
presence of CRC cells inasmuch as the mysterious role of L. buccalis ought to be further
investigated. Alongside F. nucleatum, all four species grown together have the next least amount
of burden when adapting to a rapidly shifting environment. The collective bacterial growth also
had the highest average surface area, suggesting that the four organisms grown together were
extremely savvy in exposing a well-establish biofilm structure to resources while growing among
cells that were already capable of being resource-efficient.

CONCLUDING REMARKS
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This project has attempted to evaluate the impact of anaerobic bacteria on colorectal
carcinoma by first exploring the question of whether or not these bacteria species were capable
of producing biofilms. Upon finding that they could indeed produce biofilms, the question then
turned to the exploration of how bacterial biofilms influence cellular viability of CRC cells. This
was done by establishing several co-cultured experiments and then using software programs and
algorithms to effectively analyze the relationship between the two entities. Finally, the project
explored how bacterial biofilm production and establishment is developed when co-cultured with
CRC cells.
Together these results have indicated that all four organisms are capable of producing
well-established biofilms, which is a known contributor to disease and alters the host tissue
microenvironment of the human colon. They also question the exact nature of the microbiome
when growing in presence of host cells and tissues as well as point to the obvious impact of the
microbial community on colorectal carcinoma. Particularly notable is the absence of non-viable
cells when co-cultured with L. buccalis, which prompts further investigation. In the future, it
would do well to test the growth of these species among different CRC cell lines and for longer
periods of time to effectively evaluate the relationship between bacterial biofilms and CRC.
Furthermore, later experiments should focus on monitoring the growth of normal colorectal
epithelial cells in the presence of these bacteria species via miRNA sequencing to truly examine
the microbial impact of anaerobic bacteria on CRC.
On the last note, this project did not manage to perform miRNA sequencing for
differential expression analysis to genetically evaluate the impact of bacterial biofilms on normal
colorectal epithelial cells. In the future, this option should be explored and monitored at set time
intervals in order to properly capture the progression of non-malignant cells as it goes from one
stage to the next. Furthermore, this project only did one of the fifteen different combinations that
resulted from testing four anaerobes. To truly evaluate the “driver” potential of bacterial biofilms
as well as the relationships they may exhibit, future experiments should focus on a combination
of different organisms – both in presence of and in the absence of normal colorectal epithelial
cells. While previous studies have identified all four organisms being significantly overrepresented in colorectal tumors and forming a unique microbial signature, some of the species –
such as F. nucleatum and C. showae – co-aggregated in culture. It could be that relationships
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between certain species over another could be more effective in encouraging these cells to adopt
carcinogenic characteristics.
Lastly, any meticulous observer will raise the question of why this project did not use L.
hofstadii instead of L. buccalis when the results clearly show that, although close, the former has
higher read-pair alignments associated with CRC microbial signature than the latter. To be sure,
the acquisition of L. hofstadii was relentlessly pursued but was met with obstacles and dead-ends
each time. Future experiments should undoubtedly include L. hofstadii to properly and
thoroughly examine the relationship between bacterial biofilms and CRC as well as assessing the
individual and collective role of anaerobic microbes in the carcinogenesis of the colorectal
mucosa.
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